Approved Hospital Formulary
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

lenacapavir

lenacapavir
Brand names: Yeztugo
Form Strength
SOLUTION, SUBCUTANEOUS 463.5 mg/1.5 mL
TABLET, ORAL 300 mg


Additional Information:

Formulary with Restrictions: Outpatient settings only with support through Specialty Pharmacy Services 


Last updated: Jul. 16, 2025







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.